Medical Foods Market Trends, Growth, Analysis, Scope and Outlook Report, 2025

The global Medical Foods Market size is expected to reach USD 27.20 billion by 2025, registering a CAGR of 6.7% from 2019 to 2025, according to a new report by Grand View Research, Inc. Rising geriatric population and increasing prevalence of chronic diseases are among the key factors driving the market. According to the WHO estimates published in February 2018, the population aged 60 years and above is expected to increase from 12% in 2015 to 22% by 2050. Non-communicable diseases impose a high economic burden on health systems globally. According to a study conducted by the researchers from University of Liège, Belgium, the population suffering from sarcopenia in Europe is expected to increase from 11.1% in 2016 to 12.9% in 2045.

Medical foods help treat and prevent age-related sarcopenia. Thus, the demand for medical foods in the management of chronic conditions, such as sarcopenia, is expected to augment the market development. Moreover, various public and private initiatives in the field of clinical nutrition is projected to boost the market further. A number of manufacturers are extending their capabilities in the sports nutrition market with various strategic initiatives, such as M&A and new product launches, to fulfill the escalating demand. For instance, in May 2016, Hormel Foods introduced HORMEL VITAL CUISINE, a range of Ready-to-Eat (RTE) meals, whey protein powders, and nutritional shakes. This product line was specially designed to meet the nutritional requirements of cancer patients.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/medical-foods-market

Further key findings from the study suggest:

• Orally administered medical foods accounted for the highest revenue share and are projected to maintain the dominance in future owing to ease in administration and their commercial viability
• Enteral administrationis expected to witness the fastest CAGR of 7.2% over the forecast period
• Diabetic neuropathy held the largest revenue share in 2018 owing to high disease prevalence. However, chronic kidney disorder is expected to emerge with the fastest CAGR of 9.7% from 2019 to 2025
• Institutional sales emerged as the largest sales channel segment in 2018. However, the online sales segment is projected to register the fastest CAGR during the forecast years
• Asia Pacific is among the prominent regions owing to huge geriatric population base and high burden of chronic diseases
• Danone S.A., Nestle S.A., Abbott Laboratories, Fresenius Kabi, and Mead Johnsons & Company, LLC are the major companies in the medical foods market

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog:  https://healthcareforecastreport.blogspot.com/